RT Journal Article
SR Electronic
T1 Oxidative Status of the Ultra-Processed Foods in the Western Diet
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.07.31.23293404
DO 10.1101/2023.07.31.23293404
A1 Maldonado-Pereira, Lisaura
A1 Barnaba, Carlo
A1 Medina-Meza, Ilce Gabriela
YR 2023
UL http://medrxiv.org/content/early/2023/08/05/2023.07.31.23293404.abstract
AB Ultra-processed foods (UPFs) and their nutritional value have become a trending topic in the scientific community because of their increasing demand, and their potentially adverse effects on human health. Besides the poor nutritional value attributed to UPFs, countless studies have also reported the presence of different dietary oxidized substances in these meals. DOxS are associated with several chronic diseases such as cardiometabolic diseases (CMD), cancer, diabetes, Parkinson’s, and Alzheimer’s disease. In this study, a database of DOxS and other dietary metabolites detected in 63 UPFs meals part of the Western diet is reported. Significant differences were found in DOxS and phytosterol contents between ready-to-eat and fast food (FF). Putative biomarkers were suggested for RTE (brassicasterol) and FF (7α-OH and 7β-OH), as well as for all 6 different food categories: dairy (brassicasterol), eggs & derivatives (stigmasterol and β-sitosterol), meat & poultry (7α-OH), seafood, baby food (β-sitosterol), and others (campesterol). Ideally, the use of dietary biomarkers could potentially help in the future to identify in an early stage the presence of different chronic diseases, and even, prevent their development. Nevertheless, an exposure assessment is critical to understand the exposure level of DOxS and their relationship with different chronic diseases.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was partially funded by the Centre for Research Ingredients Safety (CRIS) of Michigan State University with the GR100229 grant, and the USDA National Institute of Food and Agriculture, Hatch project MICL02526 to I.G.M.M.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors